Opportunity
SAM #NHGRI01931
NIH Procurement: Cytation 1 Cell Imaging Multi-Mode Reader for Seahorse XFe96 Enhancement
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
April 29, 2026
Respond By
May 07, 2026
Identifier
NHGRI01931
NAICS
334516, 339112
The National Institutes of Health (NIH), specifically the National Human Genome Research Institute (NHGRI), is seeking to procure a Cytation 1 Cell Imaging Multi-Mode Reader to enhance its Seahorse XFe96 Extracellular Flux Analyzer capabilities. - Government Buyer: - National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI), Office of Logistics and Acquisition Operations (OLAO) - Contracting office located at 6011 Executive Blvd., Suite 503L, Bethesda, MD 20892 - OEMs and Vendors: - BioTek Instruments (now part of Agilent Technologies) is the manufacturer of the Cytation 1 Cell Imaging Multi-Mode Reader - Products Requested: - Cytation 1 Cell Imaging Multi-Mode Reader - Quantity: 1 - No specific part number provided - Supports integrated brightfield and fluorescence imaging for cell quantification, viability assessment, and phenotypic characterization - Designed to complement the Seahorse XFe96 Extracellular Flux Analyzer - Services Requested: - Delivery and installation services - Vendor must perform all services within 1 business day of pre-scheduled delivery, including removal of debris after unloading - Unique/Notable Requirements: - Instrument must enable post-assay cell quantification and viability assessment to improve data normalization and reproducibility in cellular bioenergetics studies - Firm-fixed-price contract - Active SAM registration required for vendors - Place of Performance and Delivery: - NIH OLAO, Bethesda, Maryland (federal facility) - Period of Performance: - One-year contract with options to extend - Performance period from May 12, 2026, to May 11, 2027
Description
Cytation 1 Cell Imaging Multi-Mode Reader to Support and Enhance the Capabilities of our existing Seashore XFe96 Extra Cellular Flux Analyzer.